Japan-based Astellas Pharma and US-based startup Vir Biotechnology have entered into a global strategic collaboration to...
Hangzhou Sciwind Biosciences has announced a strategic commercialisation collaboration with Pfizer China for Ecnoglutide...
ImmunityBio, Inc., a commercial-stage immunotherapy company based in the US, has announced a partnership with Biopharma ...
US-based Catalent and South Korea-based S.Biomedics have announced a strategic partnership to support the development an...
Johnson & Johnson has announced more than $1 billion investment in a next generation cell therapy manufacturing faci...
After talks between India's Union Minister for Science and Technology (S&T) Dr Jitendra Singh and Australian&nb...
AusBiotech and Sydney‑based life sciences company creator Proto Axiom have signed a Memorandum of Understan...
The Ministry of Health and Welfare (MoHW), South Korea government, and the Korea Health Industry Development Institute (...
CARsgen Therapeutics, a company focused on developing innovative CAR T-cell therapies, has announced that through its in...
Madrigal Pharmaceuticals, Inc., a US-based biopharmaceutical company focused on delivering novel therapeutics for metabo...
Iambic, a US-based clinical-stage life science and technology company developing novel medicines using its artificial in...
Saisei Ventures, a pioneering investment firm focused on advancing Japanese biotechnology and therapeutic innovations gl...
China-based Innovent Biologics, Inc. has announced a strategic collaboration with Eli Lilly and Company, in the US, to a...
Precision for Medicine, a global leader in biomarker-driven clinical research and development, has announced the opening...
Budapest-based Gedeon Richter Plc. and Japan's Fuji Pharma Co. have announced the expansion and further strengthening of...
A world-first clinical trial will test cancer vaccines designed specifically for children with advanced or treatment-res...
Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.39 b...
South Korea-based SK bioscience will advance a novel respiratory syncytial virus (RSV) monoclonal antibody (mAb) for glo...
Australia-based startup AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha the...
Researchers have opened a ‘window to the brain’ with a new diagnostic device that can tell how deadly brain ...
AstraZeneca strengthens its weight management portfolio through a new strategic collaboration agreement with China-based...
Glaucoma is a leading cause of blindness among people who are unable to monitor and manage their intraocular pressure (I...
The Asian biopharma landscape is evolving rapidly and undergoing major shifts, expanding focus beyond generics and contr...
What was the scientific moment or data point that convinced you NK cell–derived extracellular vesicles could becom...
Singapore has one of the most advanced biotechnology industries. Singapore began building its biomedical sciences ecosys...
